CURRENT THERAPIES PRIMARY LANGERHANS CELL HYSTIOCYTOSIS
Langerhans cell histiocytosis (LCH) is a neoplastic histiocytic disorder that most commonly affects bones and skin, but it can also involve the bone marrow, liver, spleen, lungs, pituitary gland/central nervous system, and other organs. LCH is rare, but it is considerably more common in children (es...
Main Author: | Deniz Tuğcu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137923001876 |
Similar Items
-
CASE OF GUILLAIN-BARRE´ SYNDROME IN A PATIENT WITH PULMONARY LANGERHANS CELL HYSTIOCYTOSIS
by: E. V. Efremova, et al.
Published: (2019-10-01) -
Langerhans cell histiocytosis: current advances in molecular pathogenesis
by: Tommaso Sconocchia, et al.
Published: (2023-10-01) -
The current understanding on langerhans' cells and its role in oral lesions
by: Vidyadevi Chandavarkar, et al.
Published: (2020-01-01) -
2-Clorodeoxyadenosine in therapy of children with Langerhans cell histiocytosis
by: G. G. Solopova, et al.
Published: (2022-11-01) -
Langerhans cell histiocytosis
by: Xiao-ling YAN
Published: (2014-10-01)